Channels Evaluation of host transcriptional biomarkers in the diagnosis of TB disease and optimization of multi-colour immunophenotyping assay from the QuantiFERON® TB GOLD Plus cell sediments
Evaluation of the potential of Mycobacterium tuberculosis antigen-specific host biomarkers detected in QuantiFERON® TB GOLD Plus supernatants in the diagnosis of TB disease
Characterisation of T cell specificity, functional, activation and memory profiles associated with QuantiFERON TB Gold conversion and reversion
The predictive value of a QuantiFERON conversion in the development of active tuberculosis disease in adolescents
Development of immune-based TB tests suitable for resource limited settings
Evaluation of novel host markers detected in plasma and saliva as biosignatures for the rapid diagnosis of TB disease and monitoring of the response to TB treatment
Defining and assessing the spectrum of tuberculosis (TB) disease: application to diagnosis and prognosis
Evaluation of host biosignatures for targeted screening for tuberculosis at the point of care, and monitoring of the response to TB treatment
Characterization of the innate and adaptive immune systems during active TB disease and during treatment
Design and validation of molecular diagnostic assays for key prognostic biomarkers, FLT3-ITD, NPM1, DNMT3A and CEBPA in cytogenetically normal aml patients at Tygerberg Hospital, South Africa
Design, optimisation and validation of molecular diagnostic assays for BRAF p.Val600Glu and associated genetic factors within hairy cell leukemia (HCL) and HCL-like entities at Tygerberg Hospital, South Africa
Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana
Die sintese en gebruik van chemiese merkers vir biogene amienderivate wat oor asiridiene verval
Optimisation of a whole blood flow cytometry assay to aid in the diagnosis of tuberculosis by detecting intracellular cytokines released by CD4+ T-cells
Biomarker concentrations in serum and urine of patients with Ocular Tuberculosis – a prospective descriptive study.
Leveraging shotgun proteomics for optimised interpretation of data-independent acquisition data: identification of diagnostic biomarkers for paediatric tuberculosis
Marker studies of nickel silicide formation
CXCL13, CXCL10 and CXCL8 as indicators of ocular and neurological involvement in patients with ocular syphilis: an observational descriptive study
Investigating host and pathogen biomarkers of mycobacterium bovis and nontuberculous mycobacterial infection in African buffaloes (Syncerus caffer)
The biosynthesis of adrenal C 11-oxy C21 steroids, implicated in 21-hydroxylase deficiency-21-desoxycortisol and 21 desoxycortisone and their downstream metabolism
The development of an electrochemical biosensor to detect and measure autophagy flux
The application of immunological biomarkers and enhanced pathogen detection for the epidemiological characterisation of bovine tuberculosis in African Rhinoceros
Development and validation of stabilized whole blood samples expressing T-cell activation markers as quality control reference material
Biomarkers of HIV associated malignancies and of drug interaction between anti-retrovirals (ARVs) and chemotherapy
Investigation of the expression and immunogenicity of Mycobacterium tuberculosis Rv1460
